Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4281297
Max Phase: Preclinical
Molecular Formula: C36H60N2O3
Molecular Weight: 568.89
Molecule Type: Small molecule
Associated Items:
ID: ALA4281297
Max Phase: Preclinical
Molecular Formula: C36H60N2O3
Molecular Weight: 568.89
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@H]5[C@@H](C)[C@H](C)CC[C@]5(C(=O)NCCN(C)C)CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C
Standard InChI: InChI=1S/C36H60N2O3/c1-23-13-18-36(31(40)37-21-22-38(9)10)20-19-34(7)26(30(36)24(23)2)11-12-28-33(6)16-15-29(41-25(3)39)32(4,5)27(33)14-17-35(28,34)8/h11,23-24,27-30H,12-22H2,1-10H3,(H,37,40)/t23-,24+,27+,28-,29+,30+,33+,34-,35-,36+/m1/s1
Standard InChI Key: VSVBVADAHUIWOK-PNOHBZKLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 568.89 | Molecular Weight (Monoisotopic): 568.4604 | AlogP: 7.25 | #Rotatable Bonds: 5 |
Polar Surface Area: 58.64 | Molecular Species: BASE | HBA: 4 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 8.51 | CX LogP: 6.46 | CX LogD: 5.32 |
Aromatic Rings: 0 | Heavy Atoms: 41 | QED Weighted: 0.28 | Np Likeness Score: 2.20 |
1. Huang RZ, Hua SX, Liao ZX, Huang XC, Wang HS.. (2017) Side chain-functionalized aniline-derived ursolic acid derivatives as multidrug resistance reversers that block the nuclear factor-kappa B (NF-κB) pathway and cell proliferation., 8 (7): [PMID:30108853] [10.1039/C7MD00105C] |
Source(1):